Atrial Fibrillation Forecast PowerPoint PPT Presentations

Market Size – USD 9.51 billion in 2019, Market Growth - CAGR of 13.2%, Market Trends – Advancements in device technology.

The latest report by Precision Business Insights, titled “Atrial Fibrillation Market” covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.

RnRMarketResearch.com adds “Atrial Fibrillation – Epidemiology Forecast to 2023” to its store. Atrial fibrillation (AF) is a disorder of the heart’s electrical system. The condition is characterized by an irregular heart rhythm that is either too fast or too slow.

The Atrial Fibrillation Market is estimated to reach USD 14.68 Billion by 2026, according to a new report by Reports and Data.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Atrial Fibrillation Drugs in these regions, from 2012 to 2023 (forecast), covering North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Atrial Fibrillation (AF) Surgery Market size should witness significant growth due to increased prevalence of atrial fibrillation over the last few years. Rising geriatric population coupled with increased prevalence of heart diseases will drive the global atrial fibrillation surgery market size. It is most commonly occurring dysrhythmia worldwide. An estimated three million adults have diagnosed with the disease in the U.S. with its prevalence expected to reach four million by 2030, and 5.6 million by 2050. Increasing global prevalence of obesity due to sedentary lifestyle, lack of physical activity and unhealthy dietary habits will increase the number of surgeries performed. As per WHO, in 2014, about 13% of adults were obese while 39% were overweight. Obesity leads to various types of cardiac disorders and is the second leading cause of preventable death in the U.S.

The atrial fibrillation market size is expected to see rapid growth in the next few years. It will grow to $21.66 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%.

The Left Atrial Appendage Market size is estimated to reach $2,247 million by 2027. Furthermore, it is poised to grow at a CAGR of 19.7% over the forecast period of 2022-2027. The left arterial appendage is a small ear-shaped sac found in the muscle wall of the left atrium. When a person isn’t suffering from any major ailments, the blood in the left atrium and LAA is squeezed out of the left atrium into the left ventricle (bottom left chamber of the heart) as and when the heart contracts or beat. However, in cases of atrial fibrillation, the electrical impulses which guide the heart to beat do not follow the right motion or order.

Atrial Fibrillation Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $8,319 million by 2022, registering a CAGR of 13.0% during the period 2014 - 2022. Non-surgical devices segment dominated the overall market in 2015. North America was the leading geographic segment in global atrial fibrillation devices market in 2015, and is expected to maintain its leading position throughout forecast period. Read more details at: https://www.alliedmarketresearch.com/atrial-fibrillation-market

The Atrial fibrillation market was valued at US$ 6,446.08 million in 2019 and is expected to grow at a CAGR of 14.0% from 2020 to 2027 to reach US$ 18,085.96 million by 2027.

According to the latest research report by IMARC Group, The global left atrial appendage closure devices market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2032, exhibiting a growth rate (CAGR) of 16.85% during 2024-2032. More Info:- https://www.imarcgroup.com/left-atrial-appendage-closure-devices-market

This report provides comprehensive information on the therapeutic development for Atrial Fibrillation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Atrial Fibrillation and special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/atrial-fibrillation-pipeline-review-h2-2015-market/enquire-about-report

Research Beam added a report on “Atrial Fibrillation - Pipeline Review, H2 2015” Enquiry about report: http://www.researchbeam.com/atrial-fibrillation-pipeline-review-h2-2015-market/enquire-about-report

As such, the global atrial fibrillation devices market is estimated to be valued at US$ 3.9 Bn in 2020, with the market expected to exhibit a healthy CAGR of more than 14% during the forecast period (2020-2030).

"Global Atrial Fibrillation Market Research Report 2016" http://www.gosreports.com/global-atrial-fibrillation-market-research-report-2016/

Big Market Research adds a “Atrial Fibrillation Market- Size, Share, Trends, Forecast, Growth, Opportunities " Get Complete Report @ http://www.bigmarketresearch.com/global-atrial-fibrillation-2015-2019-market This report covers the present scenario and the growth prospects of the Global Atrial Fibrillation market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs such as anti-arrythmics and anticoagulants used in the treatment of atrial fibrillation. Enquire about this report @ http://www.bigmarketresearch.com/report-enquiry/170893

Atrial Fibrillation Market report categorizes the global market by Product (EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure), End User & Geography

As such, the global atrial fibrillation devices market is estimated to be valued at US$ 3.9 Bn in 2020, with the market expected to exhibit a healthy CAGR of more than 14% during the forecast period (2020-2030).

(By Procedures: Surgical Ablation- Mini Maze, Hybrid, Non-Surgical - Catheter; By Region-North America, Europe, APAC, ROW; By Country: U.S., Canada, UK, Germany, China, Japan)

The Atrial Flutter Market is estimated to reach USD 14.68 Billion by 2026, according to a new report by Reports and Data.

For more information kindly visit: https://www.bharatbook.com/healthcare-market-research-reports-732713/anticoagulants-competitive-landscape-pipeline.html Bharat Book Bureau provides the report, on “Forecast on Anticoagulants-Competitive Landscape & Pipeline Insights[2015] ” The report analyzes that Anticoagulants has lot of future scope and potential in the market.Mostly anticoagulants are being used in Venous Thromboembolism and Atrial Fibrillation.

Market reports on India presents the latest report on “Medical Lifting Sling Market by Country Forecast 2015 - 2021” http://www.maretreportsonindia.com/life-sciences-market-research-reports-13468/kmedical-lifting-sling.html The key driver for this market is the increasing number of people suffering from atrial fibrillation.

The global cardioverter defibrillator devices market size is expected to grow at a CAGR of 5.1% during the forecast period from 2021 to 2027 and estimated to reach over USD 13,300 million by 2027. The rising prevalence of cardiac complication worldwide associated with cardiac arrhythmias primarily drives the market growth. According to the latest research citings presented by the National Institute for Health (NIH), in the last 20 years the number of cases associated with atrial fibrillation has increased by almost 33% throughout the globe.

Big Market Research, EpiCast Report: Atrial Fibrillation Epidemiology Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation, to 2023. Atrial fibrillation (AF) is a disorder of the heart’s electrical system. AF is one of the most common cardiovascular diseases among the elderly, worldwide. According to the Global Burden of Disease study, AF affected approximately 33.5 million people, or 0.5% of the world''s population, in 2010, of which 20.9 million were men and 12.6 million were women. The disease burden is likely to increase in the near future due to the projected increase in the population, especially the elderly population.

the global AF surgery product market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020.

Asia Pacific Electrophysiology (EP) Market Size is estimated to cross USD 2.5 Billion By 2027. Increasing prevalence of cardiac disorders such as atrial fibrillation, atrial flutter and tachycardia among others in the region and launch of new advanced products will influence electrophysiology revenue growth during forecast period. The recent COVID-19 pandemic has negatively impacted the electrophysiology procedures upto some extent. Elective procedures were differed during the initial phase of the outbreak to reduce cross contamination in healthcare settings. However, as COVID-19 cases are declining across the globe, the APAC electrophysiology market will witness gradual growth in the future.

According to the latest research report by IMARC Group, The global left atrial appendage closure devices market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2032, exhibiting a growth rate (CAGR) of 16.85% during 2024-2032. More Info:- https://www.imarcgroup.com/left-atrial-appendage-closure-devices-market

Ablation is minimal invasion technique which involves removal of malfunctioning tissues either by surgery, chemicals or by radiofrequency. It is used in various treatments such as cancers, atrial fibrillation, cosmetology, and orthopedics, among others.

Market Size – USD 904.5 Million in 2021, Market Growth – at a CAGR of 7.0%, Market Trends – Growing Research & Development (R&D) activities in the North America region

The global fabric protection market size was USD 2.42 Billion in 2022 and is expected to reach USD 4.7 Billion in 2032, and register a revenue CAGR of 7.6% during the forecast period. Rising demand for hassle-free apparel that is easy to clean and maintain and fabric protection products in recreational activities and adventurous sports Clothing, along with increasing awareness about the harmful effects of chemicals on the environment and human health are major factors driving market revenue growth.

According to the latest research report by IMARC Group, The global left atrial appendage closure devices market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2032, exhibiting a growth rate (CAGR) of 16.85% during 2024-2032. More Info:- https://www.imarcgroup.com/left-atrial-appendage-closure-devices-market

The global pacemaker market is likely to post a CAGR of 6.5% over the forecast period of 2018-2023, asserts Market Research Future (MRFR) in an exclusive study.

Electrophysiology Market is expected to grow US$ 14,849.01 million by 2028; it is expected to register a CAGR of 10.2% from 2022 to 2028

Big Market Research “Global Heparin Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-heparin-2015-2019-market Heparin is an anticoagulant or blood thinner produced by basophils and mast cells. Though it has no effect on already formed clots, it enables the body's natural clot lysis mechanisms to function and dissolve clots. A porcine intestine or bovine lungs extract of heparin is used pharmaceutically in conditions such as DVT, pulmonary embolism, acute coronary syndrome, and atrial fibrillation to prevent clots. It is also used during surgeries to prevent clot formation.

Global cardiac pacemakers market size is expected to reach 6.14 Bn by 2028 at a rate of 6.1% segmented as implantable, external

The global emulsifiers market size is expected to reach USD 13.08 Billion at a revenue CAGR of 6.3% in 2028, according to latest analysis by Emergen Research. Rapidly rising demand for convenience and processed foods, increasing oil and gas exploration and production activities, and increasing food demand globally are some key factors driving steady market revenue growth.

The Business Research Company offers implantable loop recorders market research report 2023 with industry size, share, segments and market growth

The plasma fractionation market is projected to reach US$ 40,731.98 million by 2028 from US$ 26,575.83 million in 2021; it is expected to grow at a CAGR of 6.3% during 2021-2028.

Major players in the anticoagulants market are GlaxoSmithKline plc., Pfizer Inc., Sanofi, Mylan, Bayer AG, Boehringer Ingelheim International GmbH..... @ @ https://bit.ly/3lggW5i

The global wearable ECG monitors market size is expected to grow to $18247.9 million in 2031 at a compound annual growth rate (CAGR) of 23.8%.

The Business Research Company offers the arrhythmia monitoring devices market research report 2022 with industry size, share, segments and market growth

A new report available with decisiondatabases.com on Heparin Sodium Market which provides an in-depth analysis during the forecast period. This report focuses on top manufactures with capacity, production, price, revenue and Market share.

Download Sample Brochure @ http://bit.ly/2dS3AKM The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: US, Brazil and Canada. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Read Analysis @ http://bit.ly/2dS3HWJ

iGATE Research has released a research report on “Global Cardiac Marker Analyzer Market, Product Analysis, Companies Business & Marketing Strategy, Major Deals” Click here to view the complete report: https://www.igateresearch.com/global-cardiac-marker-analyzer-market-product-analysis-company-business-marketing-strategy-major-deals.html Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

Major players in the anticoagulants market are GlaxoSmithKline plc., Pfizer Inc., Sanofi, Mylan, Bayer AG, Boehringer Ingelheim International GmbH.... @ @ https://bit.ly/3xswTsQ

The Global Bioresorbable Scaffolds Market is growing with the rapid pace. According to a recent study report published by the Market Research Future, the Global Bioresorbable Scaffolds Market is booming and expected to gain prominence over the forecast period and is projected to grow a sound pace

The different aspects of data on the market critical data are showcased intellectually through resources such as infographics, charts, and tables.

The global endometrial ablation devices market size is expected to reach USD 1,596.9 Million at a steady revenue CAGR of 5.3% in 2028, according to latest analysis by Emergen Research. Steady endometrial ablation devices market revenue growth can be attributed to rising prevalence of gynecological disorders in women, including menorrhagia that are responsible for patients opting for advanced surgical procedures such as endometrial ablation.

Cardiovascular Devices Market Report by Regional Outlook & Growth Forecast to 2027

This report provides comprehensive information on the therapeutic development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/chronic-inflammatory-demyelinating-polyneuropathy-cidp-pipeline-review-h2-2015-market/enquire-about-report

Growing demand for smartphone applications in automobiles and advances in technology for In-Vehicle Infotainment are driving the demand for the market.

This report provides comprehensive information on the therapeutic development for Cognitive Impairment Associated with Schizophrenia (CIAS), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cognitive Impairment Associated with Schizophrenia (CIAS) and special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/cognitive-impairment-associated-with-schizophrenia-cias-pipeline-review-h2-2015-market/enquire-about-report

Understanding various facets of the global single-lead ECG monitors market, Persistence Market Research has come up with an analytical research publication titled “Single-Lead ECG Monitors Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”.

Download Sample Brochure @ http://bit.ly/2cT04fe The Short Bowel Syndrome - Market Insights, Epidemiology and Market Forecast-2020 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and rest of the world. According to DelveInsight, the forecasted patient population of SBS will increase at a CAGR of 1.73% from 2015 to 2020 and the worldwide SBS market is estimated to be 2.69 billion by 2020. Read Analysis @ http://bit.ly/2dtg8HJ

24 Market Reports provides a complete data analysis of 2017-2022 United States Heparin Sodium Report (Status and Outlook) with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts.

Download Sample Brochure @ http://bit.ly/2dkqhan DelveInsight’s Prostate cancer - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and global market trends of the %Indication"% for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Prostate cancer forecasted market share for ten years to 2020 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Prostate cancer till 2020. Read Analysis @ http://bit.ly/2erzZcN